Trial Profile
Pharmacokinetics of MP-3180 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2021
Price :
$35
*
At a glance
- Drugs Relmapirazin (Primary) ; Iohexol
- Indications Acute kidney injury
- Focus Pharmacokinetics
- Acronyms Pilot 1A
- Sponsors MediBeacon
- 15 Apr 2014 New trial record